|
||||||
Public Information Health Care Providers News Media Text Only Version |
April 13, 2006 TORONTO - The McGuinty government is moving to improve patient access to drugs through an innovative and comprehensive plan to reform Ontario's drug system, Health and Long-Term Care Minister George Smitherman announced today. "This package is about improving patient access to drugs, and to do so more quickly and more transparently," said Smitherman. "We also need to get better value for our money in order to make our drug system -- and our entire health care system -- more effective and sustainable. Better drug pricing would mean we can reinvest savings in the drug system and make sure consumers get the innovative drugs they need." Legislation introduced today will, if passed, allow for the implementation of the government's plan. The plan would :
"All of these proposed changes are designed to benefit patients. And all patients will continue to receive the drugs they currently receive," Smitherman said. "There will be no change whatsoever to benefits, to co-payments, to deductibles, or to eligibility for Ontario Drug Program recipients." Drug costs have risen more than 140 per cent since 1997 - with the government spending $3.4 billion annually on the Ontario Drug Benefit Program. Employers in the province, who use the government's drug formulary as a guide to determine what drugs they will pay for, have also been experiencing dramatic increases and now spend $2.6 billion a year. The proposed changes announced today are based on recommendations from the Drug System Secretariat, which reviewed and consulted widely on the provincial drug system and found that there were significant opportunities to provide patients with better access to drugs, and that Ontario was not getting good value for the money it spends on prescription drugs. "The work done by the Drug System Secretariat is bold," said Marc Kealey, president of the Ontario Pharmacist Association. "The changes proposed today recognize that pharmacists are critical to the success of any health care system." "The drug system changes in Ontario will greatly benefit patients in the province," said Karen Philp, National Director of Public Policy and Government Relations with the Canadian Diabetes Association. "Patients, particularly those living with a chronic disease like diabetes, will have better access to the drugs they need and they will now have a say in the decisions being made on drug funding." Today's initiative is part of the McGuinty government's plan for innovation in public health care, building a system that delivers on three priorities - keeping Ontarians healthy, reducing wait times and providing better access to doctors and nurses. For further information : Members of the media :
Members of the general public : (416) 327-4327, or (800) 268-1154
|
Media Line Toll-free : 1-888-414-4774 In Toronto : 416-314-6197 |
If you are a reporter with a question for a story, or with comments about how this News Media section could serve you better, send us an email at : media@moh.gov.on.ca. |
| return to news releases menu
| | home | central site | contact us | site map | français |
|